BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Deadline: February 8, 2027
Opportunity Number: RFA-MH-26-170
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: February 8, 2027
Status: Posted
CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Deadline: November 5, 2026
Opportunity Number: PAR-25-255
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: November 5, 2026
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.172
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-256
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.172
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-273
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.351
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Deadline: May 4, 2028
Opportunity Number: PA-25-168
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: May 4, 2028
Status: Posted
CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
Deadline: March 5, 2026
Opportunity Number: PAR-25-209
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: March 5, 2026
Status: Posted
CFDA Numbers: 93.866
Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
Deadline: April 20, 2027
Opportunity Number: RFA-ES-25-002
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: April 20, 2027
Status: Posted
CFDA Numbers: 93.113
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-203
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.859
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-202
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.859
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-170
Agency: National Institutes of Health
Open Date: November 13, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.399, 93.853, 93.866
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-167
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.393
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Deadline: September 7, 2028
Opportunity Number: PA-25-253
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: September 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.393
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-027
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.121
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-081
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393, 93.399, 93.394, 93.395
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-136
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PA-25-172
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.393
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
Deadline: March 6, 2026
Opportunity Number: PAR-25-049
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: March 6, 2026
Status: Posted
CFDA Numbers: 93.853
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-234
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-079
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.395, 93.394
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-063
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.242
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-153
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.395
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-325
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-145
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-036
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.866, 93.242
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-175
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393, 93.395, 93.394